| |
| |
|
| Insider
Information: |
Duker Jay S. |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
69,420 |
|
|
Indirect Shares
|
22,500 |
|
|
| Direct
Value |
$72,218 |
|
|
|
Indirect Value
|
$9,956 |
|
|
| Total
Shares |
91,920 |
|
|
| Total
Value |
$82,175 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
EyePoint Pharmaceuticals Inc |
EYPT |
|
2024-02-27 |
29,420 |
2024-02-27 |
22,500 |
Premium* |
|
|
Carisma Therapeutics Inc |
CARM |
Director |
2022-06-22 |
40,000 |
2022-06-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EYPT |
EyePoint Pharmaceuticals ... |
President and CEO |
• • – |
2024-02-27 |
4 |
GA |
$0.00 |
$0 |
I/I |
2,500 |
22,500 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
President and CEO |
• • – |
2024-02-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,500 |
29,420 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
President and CEO |
• • – |
2024-02-20 |
4 |
GA |
$0.00 |
$0 |
I/I |
20,000 |
20,000 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
President and CEO |
• • – |
2024-02-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
20,000 |
31,920 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
President and CEO |
• • – |
2024-02-09 |
4 |
D |
$28.80 |
$101,750 |
D/D |
(3,533) |
51,920 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
President and CEO |
• • – |
2024-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,967 |
55,453 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
President and CEO |
• • – |
2024-01-06 |
4 |
D |
$20.40 |
$133,171 |
D/D |
(6,528) |
43,486 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
President and CEO |
• • – |
2024-01-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,793 |
50,014 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
President and COO |
• – – |
2023-02-09 |
4 |
D |
$4.17 |
$17,297 |
D/D |
(4,148) |
29,221 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
President and COO |
• – – |
2023-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,967 |
33,369 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Operating Officer |
• – – |
2022-11-01 |
4 |
D |
$5.42 |
$24,276 |
D/D |
(4,479) |
21,402 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Operating Officer |
• – – |
2022-11-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,258 |
25,881 |
0 |
- |
|
| CARM |
Carisma Therapeutics Inc |
Director |
– • – |
2022-06-22 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
40,000 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Operating Officer |
• – – |
2022-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,966 |
10,623 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Operating Officer |
• – – |
2021-11-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,657 |
|
% |
|
| EYPT |
EyePoint Pharmaceuticals ... |
|
– • – |
2019-06-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,667 |
44,167 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
|
– • – |
2019-04-12 |
4 |
OE |
$1.77 |
$35,400 |
D/D |
20,000 |
37,500 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
|
– • – |
2019-04-01 |
4 |
B |
$1.89 |
$9,450 |
D/D |
5,000 |
17,500 |
0.01 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Director |
– • – |
2018-06-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,500 |
12,500 |
0 |
- |
|
19 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
